Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.

  • 2022-01
  • Clinical breast cancer 22(1)
    • Mina Shenouda
    • Renee Copley
    • Toni Pacioles
    • Yehuda Lebowicz
    • Muhammad Jamil
    • Sutoidem Akpanudo
    • Maria Tria Tirona

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 48
Population
48 nonmetastatic breast-cancer patients with Aromatase Inhibitor induced Arthralgia
Methods
Randomized, placebo-controlled, double-blind trial; TC concentrate [50 tart cherries] vs. placebo [syrup] 1:1, 1 Oz in 8 Oz water daily for 6 weeks
Blinding
Double-blind
Duration
6 weeks
Funding
Unclear

Background

Aromatase Inhibitor induced Arthralgia (AIA) can cause noncompliance leading to decreased breast-cancer survival. Effective interventions for AIA are limited. Tart cherry (TC) showed beneficial effect on musculoskeletal pain. 48 patients (Pts) randomized to TC versus placebo over 6 weeks, TC (23pts) had 34.7% mean pain decrease versus 1.4% in Placebo (25pts). TC can improve AIA in nonmetastatic breast-cancer patients.

Methods

Randomized, placebo-controlled, double-blind trial. Eligible patients with NMHPBC on AI for at least 4 weeks were randomized to TC concentrate [50 tart cherries] vs. placebo (P) [syrup] in 1:1 model. Patients instructed to consume 1 Oz of concentrate in 8 Oz water daily for 6 weeks, and document their pain intensity at baseline, weekly and at study completion in a diary using Visual Analog Scale (VAS), with 0 mm indicating no pain, and 100 mm indicating highest pain.

Results

Sixty patients were enrolled. Two patients did not complete the study due to diarrhea, and 10 patients were noncompliant. Forty-eight patients were included in the final analysis. TC group (23 pts) had 34.7% mean decrease in pain compared to 1.4% in P group (25 pts). This difference was statistically significant (Mann-Whitney U Test, P = .034).

Conclusions

Tart cherry can significantly improve AIA in nonmetastatic breast cancer patient.

Research Insights

  • TC group (23 pts) had 34.7% mean decrease in pain compared to 1.4% in P group (25 pts). This difference was statistically significant (Mann-Whitney U Test, P = .034).

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    1 Oz concentrate (equivalent to 50 tart cherries) daily

Adverse Events Reported

  • tart cherryOverall tolerability

    Two patients did not complete the study due to diarrhea, and 10 patients were noncompliant.

    Finding
    Reported
  • tart cherrydiarrhea

    Two patients did not complete the study due to diarrhea

    Finding
    Reported
Back to top